{"product_id":"the-first-1-000-days-of-gut-health-a-parents-guide-to-neonatal-intestinal-dysbiosis","title":"The First 1,000 Days of Gut Health: A Parent's Guide to Neonatal Intestinal Dysbiosis","description":"\u003cp\u003eThe trillions of microbes living in a newborn baby's intestines form a complex, dynamic community that plays a vital role in health — and when this community is disrupted, a condition called intestinal dysbiosis, the effects can be immediate and lasting. This comprehensive review article, published in the \u003cem\u003eJournal of Perinatology\u003c\/em\u003e, explores how a baby's gut microbiome develops, what causes it to go off track, and how dysbiosis may contribute to conditions ranging from a life-threatening intestinal emergency in premature infants (necrotizing enterocolitis) to long-term diseases such as obesity, type 2 diabetes, asthma, and even Alzheimer's disease. The authors emphasize that while strong circumstantial evidence links early-life dysbiosis to many health problems, proving direct cause-and-effect remains challenging — but some causal connections, such as those for type 1 diabetes and allergic disease, have been established.\u003c\/p\u003e\n\n\u003ch1\u003eThe First 1,000 Days of Gut Health: A Parent's Guide to Neonatal Intestinal Dysbiosis\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#introduction\"\u003eIntroduction: The Microscopic World Inside Your Baby's Gut\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#development\"\u003eHow the Gut Microbiome Develops in Early Life\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#prevalence\"\u003eHow Common Is Dysbiosis in Newborns?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#causes\"\u003eWhat Causes Intestinal Dysbiosis in Newborns?\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#dysbiosis-index\"\u003eMeasuring Dysbiosis: The Dysbiosis Index\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#consequences\"\u003eHealth Problems Associated with Intestinal Dysbiosis\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#mechanisms\"\u003eHow Dysbiosis Causes Disease: The Role of Short-Chain Fatty Acids\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical-implications\"\u003eWhat This Means for Patients and Families\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eWhat This Study Couldn't Prove\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Parents\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eIntestinal dysbiosis in newborns is an alteration of gut microbes linked to disease, often marked by low Bifidobacteria and high Enterobacteriaceae.\u003c\/li\u003e\n\u003cli\u003eThe first 3 years of life are critical for microbiome development; disruptions can have lasting health consequences.\u003c\/li\u003e\n\u003cli\u003eBreastfeeding supports beneficial Bifidobacteria; antibiotics for over 4 days in preterm infants may increase NEC risk.\u003c\/li\u003e\n\u003cli\u003eAcid-blocking medications in infants are associated with dysbiosis and increased NEC risk in preterm babies.\u003c\/li\u003e\n\u003cli\u003eDysbiosis is linked to many conditions, but causation is proven for only a few, including type 1 diabetes and allergic disease.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"introduction\"\u003eIntroduction: The Microscopic World Inside Your Baby's Gut\u003c\/h2\u003e\n\u003cp\u003eInside every human intestine lives an enormous community of microorganisms — trillions of them. While bacteria are the most abundant members of this community, archaea, fungi, and viruses are also present in healthy individuals. Together, they form the intestinal microbiota, a living ecosystem that coexists with its human host.\u003c\/p\u003e\n\u003cp\u003eThis microbial community is far from passive. It actively:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCompetes for and generates nutrients\u003c\/strong\u003e that the body needs\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eInfluences and is shaped by\u003c\/strong\u003e the body's innate and adaptive immune systems\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eProtects against\u003c\/strong\u003e some diseases while potentially triggering others\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eResearchers have discovered that gut microbes influence mucus production, the maturation and continuity of the epithelial layer (the thin barrier separating the intestinal contents from the rest of the body), the quality of inflammatory responses, and overall physiological balance. Particularly important, the interactions between gut microbes and the developing immune system appear to be most critical in early life.\u003c\/p\u003e\n\u003cp\u003eThe scientific understanding of these microbes has evolved. Previously, scientists categorized intestinal microbes as symbionts (where both host and microbe benefit), commensals (where the microbe benefits and the host is unharmed), or pathogens (where the microbe benefits and the host is harmed). This simple framework no longer holds. Many intestinal microbes are now better described as \u003cstrong\u003epathobionts\u003c\/strong\u003e — organisms capable of causing harm in some situations while being tolerated, or even beneficial, in others. This is because the cooperative factors that allow harmless microbes to colonize the gut share essential qualities with the virulence factors that drive disease.\u003c\/p\u003e\n\u003cp\u003eWhen this delicate balance is disturbed, the result is \u003cstrong\u003eintestinal dysbiosis\u003c\/strong\u003e — an alteration in the intestinal microbiota associated with disease. In some cases, the change can be traced to a small group of microbes, and causality can be tested in animal models by transferring the microbiota to see if the disease follows. In other cases, the relationship is more complex: dysbiosis might be the \u003cem\u003eresult\u003c\/em\u003e of a disease, merely a coincidence, or — especially in newborns — an early warning sign of problems that may not appear until much later in childhood.\u003c\/p\u003e\n\n\u003ch2 id=\"development\"\u003eHow the Gut Microbiome Develops in Early Life\u003c\/h2\u003e\n\u003cp\u003eJust as an injury to an organ during its formation (morphogenesis) can affect that organ's recovery and the systems that depend on it, disruptions during the \"formative years\" of the microbiome can have lasting consequences. The first \u003cstrong\u003e3 years of life\u003c\/strong\u003e are the most important period of microbiome development, with age-dependent shifts in the dominant types of bacteria driven by environment, diet, and medications.\u003c\/p\u003e\n\u003cp\u003eKey insights come from studies of animals raised in completely germ-free conditions. These experiments reveal just how profoundly the microbiome shapes development:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eOffspring of germ-free mothers are at \u003cstrong\u003ehigh risk for metabolic syndrome\u003c\/strong\u003e even if raised in normal conditions afterward — suggesting the microbiome's influence begins \u003cem\u003ebefore birth\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003eGerm-free mice have \u003cstrong\u003epoor growth, decreased weight, and reduced mucosal surface area\u003c\/strong\u003e in the small intestine\u003c\/li\u003e\n  \u003cli\u003eThey have \u003cstrong\u003edecreased intestinal motility\u003c\/strong\u003e (movement of food through the digestive tract)\u003c\/li\u003e\n  \u003cli\u003eThey produce \u003cstrong\u003eincreased mucus\u003c\/strong\u003e and have an \u003cstrong\u003eenlarged cecum\u003c\/strong\u003e (the pouch at the beginning of the large intestine)\u003c\/li\u003e\n  \u003cli\u003eThey experience \u003cstrong\u003emild diarrhea\u003c\/strong\u003e\n\u003c\/li\u003e\n  \u003cli\u003eThey show \u003cstrong\u003ealtered neurodevelopment\u003c\/strong\u003e, including deficiencies in stress responsivity, anxiety-like behaviors, sociability, and cognition\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWhen germ-free animals are colonized with single microbes or known microbial communities (a state called gnotobiotic, meaning \"known microbiota\"), researchers can directly observe the effects. Comparisons of germ-free, gnotobiotic, and normal (wild-type) animals demonstrate that the intestinal microbiota plays an essential role in intestinal development. These models have established a causal role for intestinal dysbiosis in several conditions, including \u003cstrong\u003esevere acute malnutrition, obesity, nonalcoholic liver disease, Alzheimer's disease, and colitis-associated colorectal cancer\u003c\/strong\u003e. Importantly, disrupting the microbiome during the early-life window in animals causes specific immune and health alterations that are \u003cem\u003enot\u003c\/em\u003e seen when the same disruption happens at a mature age — highlighting a critical \"window of opportunity\" in infancy.\u003c\/p\u003e\n\u003cp\u003eThe human immune system develops in parallel with the microbiome. The intestinal immune system is shaped by both the structural components of microbes and the products of their metabolism.\u003c\/p\u003e\n\n\u003ch2 id=\"prevalence\"\u003eHow Common Is Dysbiosis in Newborns?\u003c\/h2\u003e\n\u003cp\u003eTo understand how common dysbiosis is, scientists first need to define what a \"normal\" infant microbiota looks like — and that definition is still incomplete. However, the article offers some reasonable starting assumptions: microbial communities are dynamic and shaped by host factors, environmental factors, and available nutrients; the ancestral infant gut was shaped by the mother's vaginal, fecal, oral, and milk microbiota, as well as by horizontal transmission within families and small communities; and modern practices — hygiene, antibiotics, antiseptics, Western-style high-fat\/high-sugar diets, and infant formula — have fundamentally changed the human intestinal microbiota from that of our ancestors.\u003c\/p\u003e\n\u003cp\u003eThe earliest descriptions of breastfed infants' fecal bacteria were published by Tissier and Logan, who both found a predominance of Gram-positive, anaerobic, Y-shaped, non-motile bacteria in healthy infants. These were initially classified as a single species, \u003cem\u003eLactobacillus bifidus\u003c\/em\u003e, until the 1960s, when they were grouped under the genus \u003cstrong\u003eBifidobacterium\u003c\/strong\u003e. Different \u003cem\u003eBifidobacterium\u003c\/em\u003e species have specialized abilities: some produce the enzymes (glycosidases) needed to digest plant oligosaccharides (complex carbohydrates), while others digest milk oligosaccharides found in human breast milk. Microbes capable of consuming milk components have a competitive advantage in the infant gut.\u003c\/p\u003e\n\u003cp\u003eHere is a striking finding from the article: A review of \u003cstrong\u003e14 studies published between 1926 and 2017, including more than 300 healthy breastfed infants\u003c\/strong\u003e, documented that over that time period, the average fecal pH of breastfed infants \u003cstrong\u003erose from 5.0 to 6.5\u003c\/strong\u003e. This change is consistent with a decrease in Bifidobacteriaceae (which produce lactic acid and lower fecal pH) and increases in Clostridiaceae and Enterobacteriaceae (both associated with higher fecal pH).\u003c\/p\u003e\n\u003cp\u003eThat matters because Enterobacteriaceae are Gram-negative facultative anaerobes that include two species well known to neonatologists: \u003cstrong\u003e\u003cem\u003eEscherichia coli\u003c\/em\u003e and \u003cem\u003eKlebsiella pneumoniae\u003c\/em\u003e\u003c\/strong\u003e. Their virulence factors include flagella (for motility), fimbriae (for attaching to host cells), and toxins (that interfere with normal cellular function). An abundance of Enterobacteriaceae is considered one hallmark of dysbiosis.\u003c\/p\u003e\n\u003cp\u003eFor healthy term infants, recognizable patterns of fecal microbiota emerge, though with high individual variation. A \"first wave\" of bacterial colonization is influenced by delivery mode:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVaginally delivered babies:\u003c\/strong\u003e dominated by Enterobacteriaceae\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCesarean-delivered babies:\u003c\/strong\u003e dominated by Staphylococcaceae\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA \"second wave\" is influenced by feeding type:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBreastfed infants:\u003c\/strong\u003e dominated by Bifidobacteriaceae\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFormula-fed infants:\u003c\/strong\u003e a more diverse population including Staphylococcaceae, Clostridiaceae, Enterococcaceae, Bifidobacteriaceae, and Bacteroidaceae\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn very preterm infants, the pattern is more complex: initial colonization with Staphylococcaceae is followed by Enterobacteriaceae and then Clostrideaceae, with Bifidobacteriaceae and Lactobacillaceae characteristically delayed or absent. In both term and preterm infants, weaning and the introduction of complementary foods trigger a steady increase in microbial diversity, ultimately leading to stable, adult-like communities.\u003c\/p\u003e\n\u003cp\u003eIn broad terms, the presence of \u003cstrong\u003elow numbers of Bifidobacteriaceae and high numbers of Enterobacteriaceae and Clostridiaceae\u003c\/strong\u003e serves as a reasonable starting point to define dysbiosis in the first months of life. This pattern is common in very preterm infants, term infants requiring prolonged hospitalization or antibiotics, and even well-appearing infants in some geographic areas. The term \"microbiota immaturity\" has been coined for a delay in the patterned progression of the microbiota — a concept first described in children with severe acute malnutrition and now proposed as another useful definition of dysbiosis in infants.\u003c\/p\u003e\n\n\u003ch2 id=\"causes\"\u003eWhat Causes Intestinal Dysbiosis in Newborns?\u003c\/h2\u003e\n\u003cp\u003eMany factors can influence the infant microbiota, and some can cause dysbiosis. Here are the key contributors identified in the article:\u003c\/p\u003e\n\n\u003ch3\u003eDelivery Mode and Feeding\u003c\/h3\u003e\n\u003cp\u003eBoth mode of delivery (vaginal vs. cesarean) and feeding type (human milk vs. formula vs. a combination) significantly influence the composition of the infant microbiota. Differences in infant microbiota between home and hospital deliveries have also been reported.\u003c\/p\u003e\n\n\u003ch3\u003eMaternal Factors\u003c\/h3\u003e\n\u003cp\u003eThe mother's diet and the microbes in her milk (which generally resemble the microbiota of maternal skin and feces) influence the infant fecal microbiota, though usually to a modest extent. Maternal smoking is also associated with changes.\u003c\/p\u003e\n\n\u003ch3\u003eMedications\u003c\/h3\u003e\n\u003cp\u003eExposure to \u003cstrong\u003eintrapartum antibiotics\u003c\/strong\u003e (given to mothers during labor to prevent Group B streptococcal sepsis or because of cesarean section) is extremely common and impacts the neonatal intestinal microbiota. Other medications commonly given to mothers and\/or infants that alter the microbiota include:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAcid-blocking agents\u003c\/strong\u003e (used for reflux)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSelective serotonin reuptake inhibitors (SSRIs)\u003c\/strong\u003e (antidepressants)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMetformin\u003c\/strong\u003e (for diabetes)\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eLaxatives\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eEnvironmental Exposures\u003c\/h3\u003e\n\u003cp\u003eRecent studies have demonstrated altered infant microbiota with exposure to \u003cstrong\u003eenvironmental toxins, maternal smoking, and proximity to furry animals\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eUnique Factors in Very Preterm Infants\u003c\/h3\u003e\n\u003cp\u003eVery preterm infants are a unique population. They are \"new\" from an evolutionary standpoint, have prolonged hospital stays with multiple environmental exposures, are frequently exposed to antibiotics, and have immature immune systems. In these infants, the primary determinants of intestinal microbiota composition are \u003cstrong\u003epostmenstrual age and age in weeks\u003c\/strong\u003e, but many other factors also play a role, including antenatal corticosteroids, mode of delivery, antibiotic exposure, feeding type, feeding tube dwell time and biofilms, gender, and stress.\u003c\/p\u003e\n\n\u003ch3\u003eSpecific Microbiota Changes from Perinatal Exposures\u003c\/h3\u003e\n\u003cp\u003eThe article's Table 1 details specific alterations in infant fecal microbiota related to various exposures. Here are the highlights:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIntrapartum antibiotics:\u003c\/strong\u003e Decreased \u003cem\u003eBacteroides\u003c\/em\u003e, \u003cem\u003eParabacteroides\u003c\/em\u003e, \u003cem\u003eBifidobacterium\u003c\/em\u003e, and Actinobacteria; increased Proteobacteria, \u003cem\u003eVeillonella\u003c\/em\u003e, \u003cem\u003eEnterococcus\u003c\/em\u003e, Firmicutes, and \u003cem\u003eClostridia\u003c\/em\u003e; reduced alpha diversity (overall variety of species); lower fecal acetate; increased antibiotic resistance genes\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePostnatal antibiotics (term infants):\u003c\/strong\u003e Decreased Bacteroidetes, reduced alpha diversity, increased antibiotic resistance genes\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePostnatal antibiotics (preterm infants):\u003c\/strong\u003e Reduced alpha diversity and increased antibiotic resistance genes\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eCesarean delivery:\u003c\/strong\u003e Decreased Actinobacteria and Bacteroidetes; increased Firmicutes\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHome birth:\u003c\/strong\u003e Increased \u003cem\u003eBifidobacterium\u003c\/em\u003e, \u003cem\u003eBacteroides\u003c\/em\u003e, \u003cem\u003eStreptococcus\u003c\/em\u003e, and \u003cem\u003eLactobacillus\u003c\/em\u003e; decreased \u003cem\u003eClostridium\u003c\/em\u003e and Enterobacteriaceae\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eVery preterm birth:\u003c\/strong\u003e Increased Proteobacteria; decreased Firmicutes and \u003cem\u003eBifidobacterium\u003c\/em\u003e; lower short-chain fatty acids\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMother's own milk:\u003c\/strong\u003e Increased Bifidobacteriaceae; decreased Staphylococcaceae, Clostridiaceae, and Pasteurellaceae\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaternal smoking:\u003c\/strong\u003e Increased \u003cem\u003eRuminococcus\u003c\/em\u003e, \u003cem\u003eAkkermansia\u003c\/em\u003e, \u003cem\u003eBacteroides\u003c\/em\u003e, and \u003cem\u003eStaphylococcus\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eFurry pet in the home:\u003c\/strong\u003e Decreased Streptococcaceae; increased \u003cem\u003eOscillospira\u003c\/em\u003e and \u003cem\u003eRuminococcus\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDisinfectant use:\u003c\/strong\u003e Increased Lachnospiraceae; decreased \u003cem\u003eHaemophilus\u003c\/em\u003e\n\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEco-friendly disinfectant use:\u003c\/strong\u003e Decreased Enterobacteriaceae\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"dysbiosis-index\"\u003eMeasuring Dysbiosis: The Dysbiosis Index\u003c\/h2\u003e\n\u003cp\u003eResearchers have developed a \"dysbiosis index\" to quantify how far a person's microbiota deviates from a healthy baseline. The first such index was created for new-onset pediatric \u003cstrong\u003eCrohn's disease\u003c\/strong\u003e, based on the ratio of bacteria increased in patients with the disease (including Enterobacteriaceae, Pasteurellaceae, Veillonellaceae, Fusobacteriaceae, Neisseriaceae, and Gemellaceae) to bacteria decreased in those patients (including Erysipelotrichales, Bacteroidales, Clostridiales, and Bifidobacteriaceae). This index has diagnostic validity and correlates with symptom severity, though it did not predict response to treatment.\u003c\/p\u003e\n\u003cp\u003eA commercially available test called the \u003cstrong\u003eGA-map™ Dysbiosis Test\u003c\/strong\u003e (Genetic Analysis, Oslo, Norway) compares a patient's microbiota composition with a healthy adult control population and generates a dysbiosis index score. This score correlates with fecal calprotectin, a marker of intestinal inflammation. An elevated dysbiosis index using this product has been demonstrated in adults with \u003cstrong\u003eankylosing spondylitis\u003c\/strong\u003e (a type of inflammatory arthritis), \u003cstrong\u003eirritable bowel syndrome, inflammatory bowel disease\u003c\/strong\u003e, and \u003cstrong\u003eSjögren's syndrome\u003c\/strong\u003e (an autoimmune disease affecting moisture-producing glands).\u003c\/p\u003e\n\u003cp\u003eImportantly, \u003cstrong\u003eno dysbiosis index has yet been developed for term or preterm infants\u003c\/strong\u003e. The authors note that because the infant microbiota develops in a patterned progression, any neonatal dysbiosis index would need to incorporate gestational age and the infant's age at the time of stool collection.\u003c\/p\u003e\n\n\u003ch2 id=\"consequences\"\u003eHealth Problems Associated with Intestinal Dysbiosis\u003c\/h2\u003e\n\u003cp\u003eThe list of diseases associated with intestinal dysbiosis is long and diverse. The article's Table 2 divides them into acute\/subacute and chronic conditions.\u003c\/p\u003e\n\n\u003ch3\u003eAcute and Subacute Conditions\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNecrotizing enterocolitis (NEC)\u003c\/strong\u003e in preterm infants — a devastating intestinal emergency\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLate-onset neonatal sepsis (LOS)\u003c\/strong\u003e — bloodstream infection occurring after 72 hours of life\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAntibiotic-associated diarrhea\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eClostridium difficile\u003c\/em\u003e colitis\u003c\/strong\u003e — a severe antibiotic-related intestinal infection\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eInfant colic\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSevere acute malnutrition\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eChronic Conditions\u003c\/h3\u003e\n\u003cp\u003eThe chronic conditions associated with dysbiosis are remarkably diverse:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eType 1 diabetes and type 2 diabetes\u003c\/li\u003e\n  \u003cli\u003eChronic kidney disease\u003c\/li\u003e\n  \u003cli\u003eInflammatory bowel disease (Crohn's disease and ulcerative colitis)\u003c\/li\u003e\n  \u003cli\u003eDyslipidemia (abnormal blood fats)\u003c\/li\u003e\n  \u003cli\u003eCoronary artery disease\u003c\/li\u003e\n  \u003cli\u003eBreast cancer and colon cancer\u003c\/li\u003e\n  \u003cli\u003eAtopic dermatitis (eczema)\u003c\/li\u003e\n  \u003cli\u003eNon-alcoholic fatty liver disease\u003c\/li\u003e\n  \u003cli\u003eParkinson's disease and Alzheimer's disease\u003c\/li\u003e\n  \u003cli\u003eObesity\u003c\/li\u003e\n  \u003cli\u003eDepression and schizophrenia\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor most of these conditions, a causal link has \u003cem\u003enot\u003c\/em\u003e been established. However, causality and underlying mechanisms \u003cem\u003ehave\u003c\/em\u003e been demonstrated for some, including \u003cstrong\u003etype 1 diabetes\u003c\/strong\u003e and \u003cstrong\u003eatopic disease\/asthma\u003c\/strong\u003e. Studies of antibiotic exposure in utero or in the perinatal period and its relationship to childhood obesity, atopic dermatitis, asthma, and allergic rhinitis have produced mixed results.\u003c\/p\u003e\n\n\u003ch3\u003eNecrotizing Enterocolitis (NEC)\u003c\/h3\u003e\n\u003cp\u003eNEC is one of the most feared complications in premature infants. Careful studies of the fecal microbiota \u003cem\u003ebefore\u003c\/em\u003e disease onset revealed a characteristic pattern: at the phylum level, \u003cstrong\u003eincreased Proteobacteria and decreased Firmicutes and Bacteroidetes\u003c\/strong\u003e. At the family level, there was \u003cstrong\u003eincreased Enterobacteriaceae\u003c\/strong\u003e; at the genus level, \u003cstrong\u003eincreased \u003cem\u003eKlebsiella\u003c\/em\u003e\u003c\/strong\u003e, as well as increased fimbriae-expressing bacteria.\u003c\/p\u003e\n\u003cp\u003eSeveral studies have shown that treating preterm infants with antibiotics for \u003cstrong\u003emore than 4 days\u003c\/strong\u003e increases the risk of later developing NEC. Similarly, giving preterm infants acid-blocking agents is associated with both fecal dysbiosis and an increased risk of NEC. The article also suggests that dysbiosis in hospitalized infants is influenced by microbes on NICU surfaces, which may explain some of the wide variation in NEC rates between hospitals. One recent analysis even demonstrated a NICU \"room-specific microbiota\" shaped by the infants' gut microbes.\u003c\/p\u003e\n\n\u003ch3\u003eLate-Onset Sepsis (LOS)\u003c\/h3\u003e\n\u003cp\u003eThe case for dysbiosis in LOS is less clear, as most LOS in the NICU has been attributed to skin microbes and central catheters. However, recent investigation identified \u003cstrong\u003eidentical organisms in the feces and blood cultures\u003c\/strong\u003e of infants with LOS, suggesting that translocation of gut microbes (bacteria crossing the intestinal barrier into the bloodstream) may be a common cause. In rodent models, an abundance of specific intestinal microbes is protective against induced sepsis, while their absence is associated with increased disease severity. In preterm infants, an abundance of \u003cstrong\u003e\u003cem\u003eBifidobacterium\u003c\/em\u003e species appears to be protective\u003c\/strong\u003e — or at least a marker of protection — against LOS.\u003c\/p\u003e\n\n\u003ch3\u003eInfant Colic\u003c\/h3\u003e\n\u003cp\u003eInfant colic is common and is associated with an increased risk of long-term learning and behavioral challenges. Several studies have demonstrated an association between intestinal dysbiosis and colic, with specific bacterial types linked to symptom severity.\u003c\/p\u003e\n\n\u003ch2 id=\"mechanisms\"\u003eHow Dysbiosis Causes Disease: The Role of Short-Chain Fatty Acids\u003c\/h2\u003e\n\u003cp\u003eThe article briefly reviews the mechanisms by which dysbiosis triggers local and systemic disease, focusing on well-established pathways and promising new ones.\u003c\/p\u003e\n\n\u003ch3\u003eWell-Established Mechanisms\u003c\/h3\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAltered intestinal permeability:\u003c\/strong\u003e Gut microbes change how easily substances pass through the intestinal barrier\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAltered local and systemic inflammation:\u003c\/strong\u003e Microbes influence inflammatory responses throughout the body\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eEffects on intestinal development:\u003c\/strong\u003e In germ-free conditions or germ-free mice colonized with control feces at weaning, there is a window in early life in which the microbiota can induce a gene called \u003cstrong\u003eErdr1\u003c\/strong\u003e to alter intestinal development and the capacity for regenerative repair\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSerotonin production:\u003c\/strong\u003e Gut microbes stimulate enterochromaffin cells (specialized cells in the intestinal lining) to produce \u003cstrong\u003eserotonin\u003c\/strong\u003e, the primary neurotransmitter of the enteric (intestinal) nervous system\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eShort-Chain Fatty Acids (SCFAs)\u003c\/h3\u003e\n\u003cp\u003eShort-chain fatty acids — most commonly \u003cstrong\u003eacetate, propionate, and butyrate\u003c\/strong\u003e — are produced when gut bacteria ferment dietary fiber. They are produced by several key bacterial genera, as outlined in the article's Table 3:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eBifidobacterium\u003c\/em\u003e\u003c\/strong\u003e — produces acetate and lactate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eAkkermansia\u003c\/em\u003e\u003c\/strong\u003e — produces acetate and propionate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eFaecalibacterium\u003c\/em\u003e\u003c\/strong\u003e — produces butyrate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eClostridium\u003c\/em\u003e\u003c\/strong\u003e — produces butyrate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eEubacterium\u003c\/em\u003e\u003c\/strong\u003e — produces butyrate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eRoseburia\u003c\/em\u003e\u003c\/strong\u003e — produces butyrate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eBacteroides\u003c\/em\u003e\u003c\/strong\u003e — produces acetate and propionate\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003e\u003cem\u003eLactobacillus\u003c\/em\u003e\u003c\/strong\u003e — produces lactate\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSCFAs serve as an \u003cstrong\u003eimportant energy source for colonocytes\u003c\/strong\u003e (the cells lining the colon) and modulate insulin sensitivity, glucose and lipid homeostasis, and systemic inflammation.\u003c\/p\u003e\n\u003cp\u003eA recent large-scale analysis of genotype, fecal microbiota, and fecal SCFA levels in adults demonstrated \u003cstrong\u003ecausal associations\u003c\/strong\u003e between:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eIncreased fecal butyrate and \u003cstrong\u003eimproved insulin response\u003c\/strong\u003e after oral glucose tolerance testing\u003c\/li\u003e\n  \u003cli\u003eDecreased fecal propionate and an \u003cstrong\u003eincreased risk of type 2 diabetes\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSCFAs affect glucose metabolism through induction of intestinal gluconeogenesis (the production of new glucose in the intestine). Their role in energy metabolism may be even broader, with reported effects on appetite regulation and the gut–brain axis. In mice, SCFAs produced by maternal gut microbes influence the differentiation of \u003cstrong\u003eneural, intestinal, and pancreatic cells\u003c\/strong\u003e in the embryo by activating embryonic G protein-coupled receptors. In rabbits, the cecal microbiota changes early in the transition from suckling to weaning, resulting in increased butyrate production, which impacts intestinal permeability.\u003c\/p\u003e\n\u003cp\u003ePatients with Crohn's disease and ulcerative colitis have \u003cstrong\u003elow numbers of SCFA-producing bacteria and low levels of fecal SCFAs\u003c\/strong\u003e. Mechanisms by which SCFAs protect against inflammatory bowel disease include:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eSupporting enterocyte (intestinal cell) proliferation\u003c\/li\u003e\n  \u003cli\u003eInducing tight junction proteins to strengthen the intestinal barrier\u003c\/li\u003e\n  \u003cli\u003eInducing antimicrobial peptides\u003c\/li\u003e\n  \u003cli\u003eProducing a range of anti-inflammatory effects\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSCFAs and lactic acid are produced in abundance when human milk is combined with microbes that can consume human milk oligosaccharides — such as the \u003cem\u003eBifidobacterium\u003c\/em\u003e species that have co-evolved with breastfeeding over millions of years.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical-implications\"\u003eWhat This Means for Patients and Families\u003c\/h2\u003e\n\u003cp\u003eThis research has important implications for how we care for newborns, especially preterm infants:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAntibiotic stewardship matters:\u003c\/strong\u003e Antibiotics are life-saving in the NICU, but treating preterm infants for more than 4 days increases the risk of NEC. Every antibiotic course should be carefully justified and stopped as soon as possible.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAcid blockers are not harmless:\u003c\/strong\u003e These medications, commonly prescribed for reflux in infants, are associated with both dysbiosis and increased NEC risk in preterm infants. Parents should ask whether acid blockers are truly necessary.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBreast milk is powerful medicine:\u003c\/strong\u003e Human milk oligosaccharides selectively feed beneficial \u003cem\u003eBifidobacterium\u003c\/em\u003e species, lowering fecal pH and promoting a healthier microbial community. The article describes how mothers shape their infants' microbiota through selective nutrients and antimicrobials in breast milk.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDelivery mode has consequences:\u003c\/strong\u003e Babies born by cesarean section have a different microbial start than vaginally delivered babies. When C-sections are medically necessary, they are life-saving — but the microbial differences they create are real and may warrant extra attention to other protective factors like breastfeeding.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePrematurity itself is a risk factor:\u003c\/strong\u003e Very preterm infants have a characteristic dysbiosis pattern with delayed or absent Bifidobacteriaceae. This may contribute to their vulnerability to NEC and LOS.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"limitations\"\u003eWhat This Study Couldn't Prove\u003c\/h2\u003e\n\u003cp\u003eThe authors are candid about the limitations of the current evidence:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAssociation vs. causation:\u003c\/strong\u003e For most diseases listed in Table 2, dysbiosis has not been proven to cause the disease. It may be a result of the disease, or merely coincidental.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo established \"normal\":\u003c\/strong\u003e Our understanding of what constitutes a \"normal\" infant microbiota is incomplete, which limits our ability to define dysbiosis precisely.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigh individual variation:\u003c\/strong\u003e Even healthy infants show a high degree of individual variation in their microbiota, making it difficult to draw universal conclusions.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNo neonatal dysbiosis index:\u003c\/strong\u003e Existing dysbiosis indexes were developed for adults and children with specific diseases; none have been validated for term or preterm infants. A neonatal index would need to account for gestational age and age at stool collection.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMixed evidence:\u003c\/strong\u003e Studies linking antibiotic exposure to childhood obesity and allergic diseases have produced conflicting results.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Parents\u003c\/h2\u003e\n\u003cp\u003eWhile research is ongoing, the evidence in this review supports several practical steps for families:\u003c\/p\u003e\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBreastfeed when possible.\u003c\/strong\u003e Human milk oligosaccharides selectively feed beneficial bacteria and help establish a healthy microbial community. The difference between breastfed and formula-fed infants' microbiomes is well documented.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eAsk about antibiotics.\u003c\/strong\u003e If your baby (especially a preterm baby) is prescribed antibiotics, ask your medical team how long the course will be and whether it can be shortened or stopped once tests confirm it is safe. The risk of NEC rises with antibiotic courses lasting more than 4 days.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eQuestion acid-blocking medications.\u003c\/strong\u003e If acid blockers are recommended for your infant, ask whether they are truly needed. These medications are associated with dysbiosis and increased NEC risk in preterm infants.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eConsider the hospital environment.\u003c\/strong\u003e For families of hospitalized infants, it is reassuring to know that NICU rooms develop \"room-specific\" microbiotas shaped by the infants themselves. Hand hygiene remains crucial, and some evidence suggests that even the type of disinfectant used can influence the infant microbiome.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eDiscuss delivery mode with your obstetric provider.\u003c\/strong\u003e If a C-section is medically necessary, accept it — it can be life-saving. But if you are planning a vaginal delivery, know that it gives your baby a different, potentially beneficial microbial start.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWatch for signs of colic and communicate with your pediatrician.\u003c\/strong\u003e Colic is associated with dysbiosis and with an increased risk of long-term learning and behavioral challenges, so it deserves attention beyond simply \"waiting it out.\"\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat is intestinal dysbiosis in a newborn baby?\u003c\/h3\u003e\n\u003cp\u003eIntestinal dysbiosis is an alteration in the intestinal microbiota, the trillions of microbes in the gut, that is associated with disease. In newborns, it often means low numbers of beneficial Bifidobacteria and high numbers of Enterobacteriaceae and Clostridiaceae. This pattern is common in preterm infants and can contribute to health problems.\u003c\/p\u003e\n\u003ch3\u003eHow does a baby's gut microbiome develop in early life?\u003c\/h3\u003e\n\u003cp\u003eThe first 3 years of life are the most important for microbiome development. A first wave of bacteria is influenced by delivery mode: vaginally delivered babies are dominated by Enterobacteriaceae, while cesarean-delivered babies have more Staphylococcaceae. A second wave depends on feeding: breastfed infants are dominated by Bifidobacteriaceae, while formula-fed infants have a more diverse population.\u003c\/p\u003e\n\u003ch3\u003eWhat factors cause intestinal dysbiosis in newborns?\u003c\/h3\u003e\n\u003cp\u003eKey causes include delivery mode (cesarean vs. vaginal), feeding type (formula vs. breast milk), intrapartum antibiotics given to mothers, postnatal antibiotics in babies, acid-blocking medications, maternal smoking, and exposure to disinfectants. Very preterm infants are especially vulnerable due to prolonged hospital stays, antibiotics, and immature immune systems.\u003c\/p\u003e\n\u003ch3\u003eIs there a test to measure dysbiosis in newborns?\u003c\/h3\u003e\n\u003cp\u003eResearchers have developed a dysbiosis index that compares a person's microbiota to a healthy baseline, but no dysbiosis index has been validated for term or preterm infants. Existing tests were created for adults with conditions like Crohn's disease. A future newborn index would need to account for gestational age and age at stool collection.\u003c\/p\u003e\n\u003ch3\u003eWhat health problems are associated with newborn gut dysbiosis?\u003c\/h3\u003e\n\u003cp\u003eAcute conditions include necrotizing enterocolitis in preterm infants, late-onset sepsis, antibiotic-associated diarrhea, Clostridium difficile colitis, infant colic, and severe acute malnutrition. Chronic conditions linked to dysbiosis include obesity, type 2 diabetes, asthma, inflammatory bowel disease, atopic dermatitis, Parkinson's and Alzheimer's disease, and depression. For most, causation is not proven.\u003c\/p\u003e\n\u003ch3\u003eHow can parents help promote a healthy gut microbiome in their baby?\u003c\/h3\u003e\n\u003cp\u003eBreastfeed when possible, because human milk oligosaccharides selectively feed beneficial Bifidobacteria. Ask about antibiotics—courses over 4 days in preterm infants may increase NEC risk. Question acid-blocking medications, as they are associated with dysbiosis. Discuss delivery mode with your obstetric provider, and practice good hand hygiene, especially in the hospital.\u003c\/p\u003e\n\u003ch3\u003eDoes newborn gut dysbiosis cause long-term diseases like diabetes or asthma?\u003c\/h3\u003e\n\u003cp\u003eFor most conditions, a causal link has not been established. However, causality has been demonstrated for type 1 diabetes and allergic disease\/asthma. Studies linking antibiotic exposure to childhood obesity and allergies have produced mixed results. Dysbiosis might be a cause, a result, or only a coincidence for many chronic diseases.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Neonatal intestinal dysbiosis\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors:\u003c\/strong\u003e Mark A. Underwood, Sagori Mukhopadhyay, Satyan Lakshminrusimha, and Charles L. Bevins\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eJournal:\u003c\/strong\u003e \u003cem\u003eJournal of Perinatology\u003c\/em\u003e (2020), Volume 40, pages 1597–1608\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOI:\u003c\/strong\u003e https:\/\/doi.org\/10.1038\/s41372-020-00829-2\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublished online:\u003c\/strong\u003e September 23, 2020\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAffiliations:\u003c\/strong\u003e Department of Pediatrics, UC Davis School of Medicine, Sacramento, CA; Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Department of Medical Microbiology and Immunology, UC Davis School of Medicine, Davis, CA.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis patient-friendly article is based on peer-reviewed research. It is intended for educational purposes and does not constitute medical advice. Always consult your child's healthcare provider with questions about your baby's health.\u003c\/em\u003e\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47405674168476,"sku":null,"price":0.0,"currency_code":"EUR","in_stock":true}],"url":"https:\/\/diagnosticdetectives.fr\/products\/the-first-1-000-days-of-gut-health-a-parents-guide-to-neonatal-intestinal-dysbiosis","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}